• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Skyepharma PLC

+ Add to Watchlist


Price not available for SKYEF:US

Snapshot for Skyepharma PLC (SKYEF)

Open: - Day's Range: - Volume: 0
Previous Close: 4.3525 52wk Range: 1.2399 - 4.3525 1-Yr Rtn: -

Stock Chart for SKYEF

No chart data available.
  • SKYEF:US 4.3525
  • 1M
  • 1Y
Interactive SKYEF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SKYEF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 17.5073
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (12/2014) 0.1500
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 104.81
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SKYEF

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for SKYEF

SkyePharma plc operates a group of companies that research, develop, manufacture and market prescription pharmaceutical products. The Group's products are available in topical, oral, injectable and inhalation form.

Peter William GrantChief Executive OfficerAndrew DerodraChief Financial Officer
John MurphySecretary/General Counsel
More Company Profile & Key Executives for SKYEF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil